All Categories

Novel Inhibitor of Ubiquitin-specific Protease USP2a

Highly Muscarinic Acetylcholine Receptor (mAChR)-Selective M5-Orthosteric Antagonist

Novel inhibitor of NRF2, selectively intervening therapeutic resistance in KEAP1-deficient NSCLC tumors

Novel pan-group III mGlu positive allosteric modulator

Novel inhibitor of Low Molecular Weight Protein Tyrosine Phosphatase (LMPTP)

Novel selective K2P2.1 (TREK-1) and K2P10.1 (TREK-2) activator

A selective inhibitor of chemokine receptor CCR8

Novel selective activator of temperature- and mechano-sensitive K2P channels

Potent and specific nicotinic receptor antagonist, binding to neuronal α-bungarotoxin sites

Novel orally bioavailable inhibitor of the class I phosphoinositide 3-kinase (PI3K) alpha isoform

The first-in-class selective inhibitor of ubiquitin-activating enzymes (UAE, also known as E1 enzymes)

A potent, selective and orally bioavailable Aurora A Kinase inhibitor

Refine Search